UBS analyst Mariana Taddeo downgrades DLocal (NASDAQ:DLO) from Buy to Sell and lowers the price target from $36 to $14.
UBS Downgrades DLocal to Sell, Lowers Price Target to $14
UBS analyst Mariana Taddeo downgrades DLocal (NASDAQ:DLO) from Buy to Sell and lowers the price target from $36 to $14.
Related Posts
Steve Jobs Saw This Tech As ‘Terrible’ Idea — But Apple Could Be Bringing It To Macs Soon Anyway
Engineers at Apple Inc (NASDAQ: AAPL) are reportedly working on adding touchscreens to MacBook computers.
Pfizer’s Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion, USP, Due To The Potential Presence of Visible Particulate
Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Propofol Injectable Emulsion, USP (containing benzyl alcohol), 100 mL Single Patient Use Glass Fliptop Vial; lot DX9067, to the user level due to a